Vaccine Adjuvants Market - Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025

The concept of stimulating the response of the body’s immune system is the basis for the vaccination. Vaccines respond by facilitating the effect of the innate immune response and activating the antigen presenting calls (APCs), thereby stimulating the protective immune response to the pathogen antigens. Adjuvants are the substances that are added to the vaccines to enhance the immunological effect of extremely purified antigens that have sufficient immunostimualtory capabilities, and have been used in vaccines for many decades. Adjuvants helps vaccine work better. Some of the vaccines contain dead or weakened microbes and stimulate the produce a strong immune response. However, most of the vaccines todays contain small components of microbes such as, proteins instead of entire microbe. These vaccines must include adjuvants to ensure that body produce strong enough immune response that he does not need to be vaccinated again.

Vaccine Adjuvants Market: Drivers and Restraints

Vaccines adjuvants market is expected to be driven by increasing prevalence of conditions such as, allergy, HIV and cancer. Vaccine adjuvants market also expected to be fueled by increasing demand for the advanced treatment options and development of vaccines with improved immunization. Other factors which are also boosting the growth of vaccine adjuvants market are increasing geriatric population and prevalence of infections.

Vaccine Adjuvants Market: Segmentation

The global vaccine adjuvants market can be segmented on the basis of product type, route of administration, application category, end user and region.

On the basis of product type the global vaccine adjuvants market can be segmented into:

• Pathogen Components
• Particulate Adjuvants
• Combination Adjuvants

On the basis of route of administration the global vaccine adjuvants market can be segmented into:

• Oral
• Intramuscular
• Subcutaneous
• Intradermal
• Intranasal
• Others

On the basis of application category the global vaccine adjuvants market can be segmented into:

• Human Vaccines
• Animal Vaccines

On the basis of end use the global vaccine adjuvants market can be segmented into:

• Pharmaceutical Companies
• Research Institutes
• Contract Manufacturing Organization

Vaccine Adjuvants Market: Overview

The global vaccine adjuvants market is expected to grow significantly over the forecast period. Advanced vaccines are being developed that do not contain dead or weakened microbes but contain a part of microbes. These vaccines require adjuvants to produce a strong immunological response to the antigens administered. Particulate adjuvants segment is biggest product segment if the global vaccine adjuvants market. Because, these particles are capable of producing the strong immune response and also enhance the delivery of antigen to immune system. Combination adjuvants segment is expected to be fastest growing segment because these adjuvants have ability to stimulate the multiple protective immune response. Intramuscular vaccine segment is expected to be the largest segment of global vaccine adjuvants market over the forecast period. As this route of administration is most effective and fastest route. Other factor driving the growth of vaccines adjuvants market increasing demand for the specific and advanced treatment options.

Vaccine Adjuvants Market: Region Wise Outlook

Geographically, the global vaccine adjuvants market can be segmented into regions: North America, Latin America, Europe, Asia Pacific and Middle East & Africa. Europe is biggest market for the vaccines adjuvants in terms of revenue and is expected to continue to dominate the market due to the increasing prevalence of disease such as, cancer and infections. Vaccine adjuvants market is expected to grow significantly in North America also, as FDA has added few of adjuvant containing vaccines in their stockpile. Asia Pacific and Africa is expected to be fastest growing vaccine adjuvants market over the forecast period due to increasing prevalence of cancer, HIV, influenza, hepatitis and others. Increasing population is also a growth factor the vaccine adjuvants market. Focus of the WHO and governments to curb the various disease is also boosting the growth of vaccine adjuvants market.

Vaccine Adjuvants Market: Key Players

Some of the key players in the global vaccine adjuvants market are, InvivoGen, OZ Biosciences, Sigma-Aldrich Co. LLC, SEPPIC, SPI Pharma, Agenus, Inc., Aphios Corp, VaxLiant LLC, Vaxine Pty Ltd and Kineta, Inc. Top companies are focusing on the merger and acquisition strategies to expand into new regions.

MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.

The report provides the following information:

• Tailwinds and headwinds molding the market’s trajectory
• Market segments based on products, technology, and applications
• Prospects of each segment
• Overall current and possible future size of the market
• Growth pace of the market
• Competitive landscape and key players’ strategies

The main aim of the report is to:

• Enable key stakeholder’s in the market bet right on it
• Understand the opportunities and pitfalls awaiting them
• Assess the overall growth scope in the near term
• Strategize effectively with respect to production and distribution

MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.